N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization

Journal of Alzheimer's Disease

Volumn 43, Issue 3, 2015, Pages 915-926

  Paholikova, Kristina ^a   Salingova, Barbara ^a   Opattova, Alena ^a   Skrabana, Rostislav ^a,b   Majerova, Petra ^a   Zilka, Norbert ^a,b   Kovacech, Branislav ^a,b   Zilkova, Monika ^a,b   Barath, Peter ^a,b   Novaka, Michal ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b AXON Neuroscience SE ^*  (Slovakia)

Author keywords

Alzheimer's disease; cell compartmentation; cell nucleus; neurodegenerative diseases; tau proteins; truncation

Indexed keywords

HYBRID PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN DEGENERATION; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONFORMATIONAL TRANSITION; CYTOSOLIC FRACTION; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INTRACELLULAR SPACE; NONHUMAN; PROTEIN BINDING; PROTEIN DEFECT; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RAT; CELL NUCLEUS; CYTOPLASM; METABOLISM; NERVE CELL; PHOSPHORYLATION; TAUOPATHY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; HUMANS; NEURONS; PHOSPHORYLATION; SUBCELLULAR FRACTIONS; TAU PROTEINS; TAUOPATHIES;

EID: 84914680335     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140996     Document Type: Article

References (77)

1. Cleveland DW, Hwo SY, Kirschner MW (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116, 207-225.
2. Drubin DG, Kirschner MW (1986) Tau protein function in living cells. J Cell Biol 103, 2739-2746.
3. Sultan A, Nesslany F, Violet M, Begard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buee L, Galas MC (2011) Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 286, 4566-4575.
4. Schraen-Maschke S, Sergeant N, Dhaenens CM, Bombois S, Deramecourt V, Caillet-Boudin ML, Pasquier F, Maurage CA, Sablonniere B, Vanmechelen E, Buee L (2008) Tau as a biomarker of neurodegenerative diseases. Biomark Med 2, 363-384.
5. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95-130.
6. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24, 1121-1159.
7. Dyson HJ, Wright PE (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6, 197-208.
8. Uversky VN (2002) Cracking the folding code. Why do some proteins adopt partially folded conformations, whereas other don't FEBS Lett 514, 181-183.
9. Uversky VN (2002) Natively unfolded proteins: A point where biology waits for physics. Protein Sci 11, 739-756.
10. Uversky VN (2002) What does it mean to be natively unfolded Eur J Biochem 269, 2-12.
11. Skrabana R, Sevcik J, Novak M (2006) Intrinsically disordered proteins in the neurodegenerative processes: Formation of tau protein paired helical filaments and their analysis. Cell Mol Neurobiol 26, 1085-1097.
12. Skrabana R, Skrabanova M, Csokova N, Sevcik J, Novak M (2006) Intrinsically disordered tau protein in Alzheimer's tangles: A coincidence or a rule Bratisl Lek Listy 107, 354-358.
13. Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, Ishiguro K, Iritani S, Tsuchiya K, Iseki E, Yagishita S, Oda T, Mochizuki A (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55, 72-79.
14. Lee S, Shea TB (2012) Caspase-mediated truncation of tau potentiates aggregation. Int J Alzheimers Dis 2012, 731063.
15. Petratos S, Li Q-X, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar M-I, Small DH (2008) The-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131, 90-108.
16. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M(1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
17. Raychaudhuri S, Majumder P, Sarkar S, Giri K, Mukhopadhyay D, Bhattacharyya NP (2008) Huntingtin interacting proteinHYPKis intrinsically unstructured. Proteins 71, 1686-1698.
18. Raychaudhuri S, Sinha M, Mukhopadhyay D, Bhattacharyya NP (2008) HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperonelike activity. Hum Mol Genet 17, 240-255.
19. DiFiglia M, Sapp E, Chase KO,Davies SW, Bates GP,Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
20. Amadoro G, Serafino AL, Barbato C, Ciotti MT, Sacco A, Calissano P, Canu N (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ 11, 217-230.
21. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, TrottierY, Richards WG, Osmand A, Paganetti P, Bates GP (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285, 8808-8823.
22. Lunkes A, Lindenberg KS, Ben-Haiem L,Weber C, Devys D, Landwehrmeyer GB, Mandel JL, Trottier Y (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 10, 259-269.
23. Novak M (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 38, 173-189.
24. Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GV (2009) Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: Implications for the pathogenesis of Alzheimer disease. J Biol Chem 284, 18754-18766.
25. Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: Accumulation of calpain/caspase fragments in the nucleus. J Biol Chem 279, 20211-20220.
26. Hackam AS, Hodgson JG, Singaraja R, Zhang T, Gan L, Gutekunst CA, Hersch SM, Hayden MR (1999) Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin. Philos Trans R Soc Lond B Biol Sci 354, 1047-1055.
27. Schilling G, Wood JD, Duan K, Slunt HH, Gonzales V, Yamada M, Cooper JK, Margolis RL, Jenkins NA, Copeland NG, Takahashi H, Tsuji S, Price DL, Borchelt DR, Ross CA (1999) Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 24, 275-286.
28. Majumder P, Raychaudhuri S, Chattopadhyay B, Bhattacharyya NP (2007) Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cell Mol Neurobiol 27, 1127-1145.
29. Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A, Hayden MR, Li Y, Cooper JK, Ross CA, Govoni S, Vincenz C, Cattaneo E (2000)Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20, 3705-3713.
30. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.
31. Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 27, 2803-2820.
32. Pesiridis GS, Tripathy K, Tanik S, Trojanowski JQ, Lee VM (2011) A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem 286, 18845-18855.
33. Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VM (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 284, 8516-8524.
34. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci USA 88, 5837-5841.
35. Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85, 4884-4888.
36. Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R,Walker JE, Milstein C, Roth M, Klug A (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85, 4506-4510.
37. Kovacech B, Novak M (2010) Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease. Curr Alzheimer Res 7, 708-716.
38. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
39. Bondareff W, Wischik CM, Novak M, Amos WB, Klug A, RothM(1990) Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol 137, 711-723.
40. Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12, 365-370.
41. Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, NovakM(2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580, 3582-3588.
42. Alonso A, Zaidi T, NovakM, Grundke-Iqbal I, IqbalK(2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98, 6923-6928.
43. Wang JZ, Grundke-Iqbal I, Iqbal K (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25, 59-68.
44. Filipcik P, Zilka N, Bugos O, Kucerak J, Koson P, Novak P, Novak M (2012) First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging 33, 1448-1456.
45. Cente M, Filipcik P, Pevalova M, NovakM(2006) Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur J Neurosci 24, 1085-1090.
46. Zilka N, Korenova M, Novak M(2009) Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol 118, 71-86.
47. Zilkova M, Zilka N,Kovac A,Kovacech B, Skrabana R, Skrabanova M, Novak M (2011) Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model. J Alzheimers Dis 23, 161-169.
48. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
49. Loomis PA, Howard TH, Castleberry RP, Binder LI (1990) Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci USA 87, 8422-8426.
50. Nardozzi JD, Lott K, Cingolani G (2010) Phosphorylation meets nuclear import: A review. Cell Commun Signal 8, 32.
51. Pei JJ, Gong CX, An WL,Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K (2003) Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogenactivated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 163, 845-858.
52. Greenwood JA, Johnson GV (1995) Localization and in situ phosphorylation state of nuclear tau. Exp Cell Res 220, 332-337.
53. Gasiorowski JZ, Dean DA (2003) Mechanisms of nuclear transport and interventions. Adv Drug Deliv Rev 55, 703-716.
54. Axelrod D, Koppel DE, Schlessinger J, Elson E, Webb WW (1976) Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys J 16, 1055-1069.
55. Hinrichs MH, Jalal A, Brenner B, Mandelkow E, Kumar S, Scholz T (2012) Tau protein diffuses along the microtubule lattice. J Biol Chem 287, 38559-38568.
56. Samsonov A, Yu JZ, Rasenick M, Popov SV (2004) Tau interaction with microtubules in vivo. J Cell Sci 117, 6129-6141.
57. Brandt R, Leger J, Lee G (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131, 1327-1340.
58. Cuchillo-Ibanez I, Seereeram A, Byers HL, Leung KY,Ward MA, Anderton BH, Hanger DP (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J 22, 3186-3195.
59. Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84, 361-384.
60. Jans DA (1995) The regulation of protein transport to the nucleus by phosphorylation. Biochem J 311(Pt 3), 705-716.
61. Franca-Koh J, Yeo M, Fraser E, Young N, Dale TC (2002) The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. J Biol Chem 277, 43844-43848.
62. Goedert M, Jakes R, Qi Z,Wang JH, Cohen P (1995) Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 65, 2804-2807.
63. Sontag E, Nunbhakdi-CraigV, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL, 3rd, Mumby MC, Bloom GS (1999) Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 274, 25490-25498.
64. Li X, Song S, Liu Y, Ko SH, Kao HY (2004) Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J Biol Chem 279, 34201-34208.
65. Alonso AD, Di Clerico J, Li B, Corbo CP, Alaniz ME, Grundke-Iqbal I, Iqbal K (2010) Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration. J Biol Chem 285, 30851-30860.
66. Yu JZ, Kuret J, Rasenick MM (2002) Transient expression of fluorescent tau proteins promotes process formation in PC12 cells: Contributions of the tau C-terminus to this process. J Neurosci Res 67, 625-633.
67. Freitas N, Cunha C (2009) Mechanisms and signals for the nuclear import of proteins. Curr Genomics 10, 550-557.
68. Chahine MN, Pierce GN (2009) Therapeutic targeting of nuclear protein import in pathological cell conditions. Pharmacol Rev 61, 358-372.
69. Jakel S, Albig W, Kutay U, Bischoff FR, Schwamborn K, Doenecke D, Gorlich D (1999) The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J 18, 2411-2423.
70. Mandelkow E, von Bergen M, Biernat J, Mandelkow EM (2007) Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol 17, 83-90.
71. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081.
72. Fushimi K, Verkman AS (1991) Low viscosity in the aqueous domain of cell cytoplasm measured by picosecond polarization microfluorimetry. J Cell Biol 112, 719-725.
73. Luby-Phelps K (1993) Effect of cytoarchitecture on the transport and localization of protein synthetic machinery. J Cell Biochem 52, 140-147.
74. Luby-Phelps K, Mujumdar S, Mujumdar RB, Ernst LA, Galbraith W, Waggoner AS (1993) A novel fluorescence ratiometric method confirms the low solvent viscosity of the cytoplasm. Biophys J 65, 236-242.
75. Krylova SM, Musheev M, Nutiu R, Li Y, Lee G, Krylov SN (2005) Tau protein binds single-stranded DNA sequence specifically-the proof obtained in vitro with non-equilibrium capillary electrophoresis of equilibrium mixtures. FEBS Lett 579, 1371-1375.
76. Padmaraju V, Indi SS, Rao KSJ (2010) New evidences on tau-DNA interactions and relevance to neurodegeneration. Neurochem Int 57, 51-57.
77. Camero S, Benitez MJ, Barrantes A, Ayuso JM, Cuadros R, Avila J, Jimenez JS (2014) Tau protein provides DNA with thermodynamic and structural features which are similar to those found in histone-DNA complex. J Alzheimers Dis 39, 649-660.